We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$481B
AUM Growth
-$11.2B
Cap. Flow
+$6.33B
Cap. Flow %
1.32%
Top 10 Hldgs %
27.75%
Holding
13,532
New
1,585
Increased
5,250
Reduced
4,926
Closed
1,614

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.26B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12B
3
AAPL icon
Apple
AAPL
+$986M
4
AMZN icon
Amazon
AMZN
+$676M
5
KVUE icon
Kenvue
KVUE
+$501M

Sector Composition

Rank Sector Weight
1 Technology 2.36%
2 Consumer Discretionary 1.65%
3 Financials 1.08%
4 Healthcare 0.89%
5 Communication Services 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICCM icon
11676
IceCure Medical
ICCM
$7.81M
$8.6K ﹤0.01%
+517
New +$16.3K
REVB icon
11677
Revelation Biosciences
REVB
$3.98M
$8.56K ﹤0.01%
+2
New +$8.82K
PIIIW icon
11678
P3 Health Partners Inc Warrant
PIIIW
$132K
$8.5K ﹤0.01%
50,000
AQB icon
11679
CALL
AquaBounty Technologies
AQB
$6.85M
$8.47K ﹤0.01%
1,765
BLIN icon
11680
Bridgeline Digital
BLIN
$12.3M
$8.47K ﹤0.01%
+10,191
New +$10.5K
LIDR icon
11681
CALL
AEye
LIDR
$57.2M
$8.32K ﹤0.01%
+1,320
New +$10.6K
RDHL
11682
CALL
Redhill Biopharma
RDHL
$3.68M
$8.21K ﹤0.01%
644
MARK
11683
CALL
DELISTED
Remark Holdings, Inc.
MARK
$8.15K ﹤0.01%
+16,300
New +$12.4K
NXL icon
11684
Nexalin Technology
NXL
$7.02M
$8.07K ﹤0.01%
+18,224
New +$11.4K
NOGN
11685
DELISTED
Nogin, Inc. Common Stock
NOGN
$8.02K ﹤0.01%
+14,353
New +$11.6K
CMND icon
11686
Clearmind Medicine
CMND
$2.54M
$7.96K ﹤0.01%
+4
New +$18.3K
BNIXR
11687
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$7.82K ﹤0.01%
31,395
-6,303
-17% -$1.28K
AEY
11688
DELISTED
ADDvantage Technologies Group
AEY
$7.65K ﹤0.01%
2,012
+465
+30% +$2.3K
HLTH
11689
CALL
DELISTED
Cue Health Inc. Common Stock
HLTH
$7.57K ﹤0.01%
17,200
AFIB
11690
DELISTED
Acutus Medical Inc
AFIB
$7.49K ﹤0.01%
+10,753
New +$6.97K
ZOM
11691
DELISTED
Zomedica Corp.
ZOM
$7.48K ﹤0.01%
+44,745
New +$8.69K
NEXI
11692
DELISTED
NexImmune, Inc. Common Stock
NEXI
$7.08K ﹤0.01%
1,417
+976
+221% +$6.06K
VNRX icon
11693
CALL
VolitionRx Ltd
VNRX
$5.25M
$7.04K ﹤0.01%
510
-1,720
-77% -$42.5K
ONCT
11694
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$6.79K ﹤0.01%
1,120
+184
+20% +$1.3K
ATER icon
11695
PUT
Aterian
ATER
$7.55M
$6.63K ﹤0.01%
+1,675
New +$8.67K
EIGR
11696
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$6.62K ﹤0.01%
723
-658
-48% -$13.2K
NMRD
11697
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$6.53K ﹤0.01%
+20,230
New +$14K
CELG.RT
11698
Bristol-Myers Squibb Rights
CELG.RT
$244M
$6.45K ﹤0.01%
67,840
-5,734
-8% -$586
SUNW
11699
DELISTED
Sunworks, Inc.
SUNW
$6.36K ﹤0.01%
12,222
-4,700
-28% -$5.04K
INUV icon
11700
Inuvo
INUV
$11.8M
$6.35K ﹤0.01%
+2,967
New +$6.84K

Similar funds

Jeff Yass's Q3 2023 Portfolio in Review

As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
  • Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
  • Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
  • Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
  • Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
  • Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.